PUBLIC COMPANY
save$BCYCBICYCLE THERAPEUTICS PLC
$BCYCCambridge, GBupdated 21d ago
community read0 votes
pipeline
2
marketed
0
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(2)
pipeline depth2 products
2Phase 2
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Insider activity
source: SEC Form 4open-market buys + sells
- Apr 6, 26SELLLee Kevin· CHIEF EXECUTIVE OFFICER−$9K↗
- Apr 6, 26SELLSkynner Michael· CHIEF SCIENTIFIC OFFICER−$3K↗
- Apr 6, 26SELLPerry Jennifer Scott· Chief Operating Officer−$2K↗
- Apr 6, 26SELLHannay Michael Charles Ferguson· CHIEF PROD & SUPPLY CHAIN OFF−$1K↗
- Apr 6, 26SELLThompson Travis Alvin· Chief Financial Officer−$515↗
- Apr 6, 26SELLPerry Jennifer Scott· Chief Operating Officer−$187↗
- Apr 2, 26SELLLee Kevin· CHIEF EXECUTIVE OFFICER−$29K↗
- Apr 2, 26SELLSkynner Michael· CHIEF SCIENTIFIC OFFICER−$9K↗
- Apr 2, 26SELLHannay Michael Charles Ferguson· CHIEF PROD & SUPPLY CHAIN OFF−$7K↗
- Apr 2, 26SELLPerry Jennifer Scott· Chief Operating Officer−$5K↗
- Apr 2, 26SELLThompson Travis Alvin· Chief Financial Officer−$4K↗
🐶 Hiring Signal
News
- Capivasertib/Fulvestrant Yields Numerical OS Advantage in PIK3CA/AKT1/PTEN–Altered Breast CancerCapivasertib plus fulvestrant generated a numerical OS benefit vs placebo plus fulvestrant in PIK3CA/AKT1/PTEN-altered advanced breast cancer.onclive · 3mo ago
- Fierce Biotech Layoff Tracker 2026: Kolon cuts workforce after ph. 3 fail; Sanofi sheds 229 staffersAs always, if you know of layoffs occurring at a biotech, please reach out to the Fierce Biotech editorial team.fiercebiotech · 8mo ago
Data sources
last refreshed 17m ago
Found something off?
comments(0)
5-min edit window · permanent after that